Variable | Entire cohort |
---|---|
Number of patients | 5215 |
Median age (years)(IQR) | 66 (60–71) |
Mean BMI (kg/m2) | 24.3 ± 2.7 |
Diabetes mellitus (%) | 742 (14.2) |
Median PSA (ng/mL)(IQR) | 6.4 (4.3–10.5) |
Mean prostate volume (mL) | 45.6 ± 22.5 |
IPSS (%) | |
Mild | 1835 (35.2) |
Moderate | 2439 (46.8) |
Severe | 941 (18.0) |
Year of prostate biopsy (%) | |
2003–2007 | 2348 (45.0) |
2008–2013 | 2867 (55.0) |
Antibiotic prophylaxis (%) | |
Quinolone | 990 (19.0) |
Third-generation cephalosporin | 4225 (81.0) |
Number of biopsy cores (%) | |
≤ 12 | 3470 (66.5) |
≥ 13 | 1745 (33.5) |
Pathologic diagnosis after biopsy (%) | |
Carcinoma | 1780 (31.4) |
Prostatitis | 438 (8.4) |
Others | 2.997 (57.5) |
Admission for infectious complications (%) | 28 (0.54) |